DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
Over millennia, there has been a seamless continuum of technologies for genetic modification of plants, animals, and microorganisms, with progressive improvements in precision and predictability – a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果